Synovial Fluid Cytokines, Chemokines and MMP Levels in Osteoarthritis Patients with Knee Pain Display a Profile Similar to Many Rheumatoid Arthritis Patients
Background: There are currently no effective disease-modifying drugs to prevent cartilage loss in osteoarthritis and synovial fluid is a potentially valuable source of biomarkers to understand the pathogenesis of different types of arthritis and identify drug responsiveness. The aim of this study wa...
Guardado en:
Autores principales: | Richard T. Meehan, Elizabeth A. Regan, Eric D. Hoffman, Molly L. Wolf, Mary T. Gill, James L. Crooks, Prashant J. Parmar, Richard A. Scheuring, John C. Hill, Karin A. Pacheco, Vijaya Knight |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d985528fdd974d5eb22c806dcdbba844 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
ANGIOGENIC AND ANGIOSTATIC CHEMOKINES LEVEL IN NORMAL SYNOVIAL FLUID
por: D. A. Zhebrun, et al.
Publicado: (2014) -
Increase in Tryptase and Its Role in the Synovial Membrane of Overweight and Obese Patients with Osteoarthritis of the Knee
por: Takata K, et al.
Publicado: (2020) -
Editorial: Synovial Tissue: Turning the Page to Precision Medicine in Arthritis?
por: Carl Kieran Orr, et al.
Publicado: (2021) -
Influence of Glucocorticoids on Cellular Senescence Hallmarks in Osteoarthritic Fibroblast-like Synoviocytes
por: Olivier Malaise, et al.
Publicado: (2021) -
Biochemical changes of synovial fluid in patients with osteoporosis of knee joint of various etiology
por: Y. L. Matveyeva, et al.
Publicado: (2013)